Analysis of clinical stage T2 prostate cancer: do current subclassifications represent an improvement?
Cagiannos I, Graefen M, Karakiewicz PI, Ohori M, Eastham JA, Rabbani F, Fair W, Wheeler TM, Hammerer PG, Haese A, Erbersdobler A, Huland H, Scardino PT, Kattan MW.
Cagiannos I, et al. Among authors: graefen m.
J Clin Oncol. 2002 Apr 15;20(8):2025-30. doi: 10.1200/JCO.2002.08.123.
J Clin Oncol. 2002.
PMID: 11956261